SOSV At The Close Of 2024
The past year has been remarkable year for SOSV. In April, we announced SOSV’s $306 million Fund V, our largest yet.
Recent news
Announcing SOSV’s Biomanufacturing VC-Founder Matchup – April 21-25, 2025 (Virtual, Free)
Welcome to the Biomanufacturing Matchup Event, where biology meets bold ambition. EXPECTED > 200 startups | 200 investors | 1 week of virtual meetings | FreeUPDATE (APR.14) > There are already 250+ startups and 250+ investors registered! From sustainable jet fuel to protein production, from next-gen pharmaceuticals to high-performance biomaterials—there are few limits to what […]
Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain
We’re thrilled to announce that Samphire Neuroscience, a graduate of our HAX hard tech startup development program, has secured $5 million Seed round led by Inventure VC with participation from Fortify Ventures. Earlier this year, the company launched Nettle—a CE-certified, non-hormonal neurotechnology device designed to relieve mental and physical symptoms tied to menstruation. Using gentle transcranial […]

Announcing SOSV’s VC-Founder Human Health Matchup – June 23-27, 2025 (Virtual, Free)
SOSV is hosting a completely free VC-Founder virtual matchmaking event focused on Health Tech. The 1:1 meetings will be taking place online between Monday, June 23 and Friday, June 27. 800+ startups | 400+ investors | 1 week of 1:1 meetings | Virtual | FreeThe largest event of its kind! Event Description The event is […]
IndieBio SF is hosting 3 events during SF Climate Week (April 21-25)
San Francisco Climate Week is around the corner, and the IndieBio team is gearing up for a dynamic week of thought-provoking conversations with leaders at the forefront of climate tech. We’re excited to invite you to three incredible events focused on the intersection of innovation, investment, and impact. Details below: 🤖 Breakthroughs in AI x […]
IndieBio NY’s Demo Day Kickoff Video
SOSV’s IndieBio NY just held a demo day at its offices in Manhattan. Fifteen spectacular deep tech founders tackling human and planetary health took the stage in front of a packed audience of investors. The IndieBio NY team made this terrific video to kick off the event and introduce the main deep tech themes of […]

Meet Deborah Zajac, SOSV and IndieBio NY’s new General Partner
Introducing Deborah Zajac, SOSV’s newest general partner and member of the IndieBio NY team.
Oxyle has raised $16M to rid water supplies of Forever Chemicals (PFAS)
Zurich-based Oxyle recently raised a $16M seed round led by 360 Ventures with participation from Axeleo Capital, Founderful and SOSV, according to a report in Forbes. Water supplies around the world are contaminated with “Forever Chemicals,” or the 10,000 perfluoroalkyl and polyfluoroalkyl substances known by the acronym PFAS. They are linked to a sharp increases […]
Rybodyn Discovers Cryptic Human Proteome, Secures $4M for Novel Cancer Immunotherapy Advancements
Rybodyn, Inc. is making waves in biotech with its groundbreaking discovery of a cryptic human proteome and a $4 million pre-seed funding round.
Proton Intelligence closes a $6.95M seed round for continuous potassium monitoring
Proton Intelligence has raised a $6.95M seed round to accelerate their work on a continuous potassium monitor that aims revolutionize clinical care for at risk patients.

SOSV At The Close Of 2024
The past year has been remarkable year for SOSV. In April, we announced SOSV’s $306 million Fund V, our largest yet.